在西班牙用设备辅助疗法治疗帕金森病患者的个人资料. 一个比较的多中心观测研究
Diego Santos-García1,2,3,4, Ángela Solleiro2, Guillermo González-Ortega5
1CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Movement disorders clinical practice
|July 24, 2025
概括
在西班牙,皮下疗法和深度大脑刺激 (DBS) 是2024年帕金森病最常见的设备辅助疗法. 患者的个人资料在不同的DAT中有很大的差异,这表明了量身定制的治疗方法.
科学领域:
- 神经学 神经学
- 医疗器械 医疗器械
- 临床实践 临床实践
背景情况:
- 设备辅助疗法 (DAT) 是对帕金森病 (PD) 的新兴治疗方法.
- 关于DAT指示和患者特征的现实数据对于理解当前的临床实践至关重要.
研究的目的:
- 为了确定西班牙神经病学家指出的特定DAT.
- 为了比较临床实践中使用的不同DAT的患者特征.
主要方法:
- 分析来自DATs-PD GETM西班牙注册表 (REDCap) 的数据.
- 一项描述性,观察性,前性,多中心研究,包括313名用DAT治疗的PD患者.
- 包括从V1 (DAT表示) 到2024年12月31日的数据.
主要成果:
- 皮下注射的利沃多帕/斯卡比多帕 (47%),深度大脑刺激 (DBS) (20.1%) 和持续皮下注射阿波莫尔芬输液 (CSAI) (19.8%) 是最常见的DAT.
- 23.6%的患者之前有DAT经验,47%的患者接受了按需治疗.
- 在DAT组之间观察到年龄,疾病持续时间,运动状况和生活质量的显著差异,DBS患者更年轻,进展较低,而LECIG患者更受影响.
结论:
- 皮下疗法和DBS占2024年西班牙实施的DAT的86.9%.
- 不同类型的DAT与不同的患者个人资料有关,突出显示了个性化治疗策略的必要性.
相关概念视频
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:15Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K